# Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D

> **NCT03105310** · PHASE2 · UNKNOWN · sponsor: **Aga Khan University** · enrollment: 20 (estimated)

## Conditions studied

- Hepatitis D, Chronic

## Interventions

- **DRUG:** Pegylated interferon alfa
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT03105310
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03105310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03105310, "Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03105310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*